Samuel L. Katz, MD
|Dr. Katz, the Wilburt Cornell Davison
Professor and Chairman Emeritus of Pediatrics at Duke University, is an honors graduate of
Dartmouth College and Harvard Medical School. After medical internship at Beth Israel
Hospital he completed Pediatrics residency training at the Massachusetts General Hospital
and the Boston Children's Hospital, followed by a research fellowship in virology and
infectious diseases, and then became a staff member at Children's Hospital working with
Nobel Laureate John J. Enders. He remained with Enders for 12 years during which time they
developed the attenuated measles virus vaccine now used throughout the world. Katz' career
has been devoted to infectious disease research focusing principally on vaccine research
and development. In addition, to his investigations of measles, he has been involved in
studies of vaccinia, polio, rubella, influenza, pertussis, HIV, Haemophilus influenzae
b conjugates and many others.
He has Chaired the Committee on Infectious Diseases of the American Academy of Pediatrics (the Redbook Committee), the Advisory Committee on Immunization Practices (ACIP) of the CDC, the Vaccine Priorities Study of the Institute of Medicine (IOM), and several WHO and CVI vaccine and HIV panels. He is a member of many scientific advisory committees and boards including the NIH, IOM, WHO, St. Jude Children's Research Hospital, The Burroughs Wellcome Fund (Chairman), and the Hasbro Children's Foundation. He was Chairman of the Public Policy Council of the Infectious Diseases Society of America (IDSA) and currently co-chairs IDSA's Vaccine Initiative.
[2009 Jan] Tayloe, Offit, Minshew, Katz, Snyderman, et. al.: Feeding a Hungry Lie By J.B. Handley
For 22 years, Dr. Katz was Chairman of the Department of Pediatrics at Duke University School of Medicine. Having relinquished the Chairmanship in 1990, his principle activities now are with vaccines and pediatric AIDS. He participates in the clinical research trials of the NIH, served on their Committee for AIDS Vaccines, devotes time each week to the care of children with HIV infection, and was a member of The Pediatric Executive Committee of NIAID's ACTG. His vaccine policy work continues through CDC, IOM, NIH, IDSA and WHO committees and consultancies.
"The most senior and respected pro-vaccine scientist (Dr. Sam Katz, former ACIP Chairman, with ties to the American Academy of Pediatrics and Infectious Disease Society of America) LIED UNDER OATH (perjury) and was exposed for doing so by Chairman Burton. Katz stated categorically that the whole cell pertussis vaccine was not given in the US anymore. He was immediately contradicted by CDC officials and Dr. Kennedy of the University of Oklahoma, who stated that the whole cell pertussis vaccine is used in combination vaccines because the acellular pertussis does not have the intended response in vaccine cocktails."---Herb Ray
"Dr. Samuel Katz of Duke University has served as chair of both the ACIP and the Red Book committees. He co-chairs a group called the Vaccine Initiative, which is an information and advocacy group that benefited from start-up funds from at least six vaccine manufacturers. He is listed as an advisory board member to the Immunization Action Coalition (which includes the Coalition for Hepatitis B), an advocacy group that receives funding from several vaccine makers, including SmithKline Beecham, Merck and Wyeth-Lederle........Dr. Neal Halsey of Johns Hopkins University. Like Katz, he is a vaccine pioneer and served on ACIP and the Red Book committees. He, too, is an advisor to the Immunization Action Coalition and the Hepatitis B Coalition. Halsey is also director of the Institute for Vaccine Safety, which he founded at Johns Hopkins to provide a forum on vaccine safety, among other things. According to a Johns Hopkins' spokesperson, the institute receives funds from Merck, SmithKline Beecham, North American Vaccines, Connaught/Pasteur Merrieux and Wyeth-Lederle."----Nicholas Regush ABCNEWS.com
THE National Network for Immunization Information http://www.idsociety.org/vaccine/index.html
The composition of the Steering Committee is: Samuel L. Katz, MD, Professor Emeritus of Pediatrics, Duke University (Co-Chair)
"He (Katz) co-chairs a group called the Vaccine Initiative http://www.vaccines.ch/intro.htm , which is an information and advocacy group that benefited from start-up funds from at least six vaccine manufacturers. He is listed as an advisory board member to the Immunization Action Coalition (which includes the Coalition for Hepatitis B), an advocacy group that receives funding from several vaccine makers, including SmithKline Beecham, Merck and Wyeth-Lederle."---Nicholas Regush ABCNEWS.com
Sunday, November 12th on CBS TV 60 Minutes, Dr. Samuel Katz said on the show MMR Vaccine and Autism, that there was no autism epidemic.
Dr. Samuel L. Katz, Edmonston B vaccine and Ethics Scandal over experiment on Isolated Indians
Vax Katz Slaps Back at Cracks
1991 - Dr. Samuel Katz and his ACIP committee would
recommend the largest increase in the amounts of mercury U.S. children would
receive by 18 months old. Further, this 1991 ACIP committee made a second
detrimental recommendation: newborns prior to leaving the hospital receive a
mercury-containing vaccine (hepatitis B). In 1999, the CDC will initiate its own
study on the incidence of autism resulting in children exposed to various levels
of mercury in Thimerosal-containing vaccines. Dr. Thomas Verstraeten is the lead
researcher on the study. In a Dec. 17, 1999 email (entitled “It just won’t go
away!”) to his colleagues in the NIP, Verstraeten reports "all the harm is done
in the first month of life.”
From UPI article it is revealed
“Some of the officials involved in the agency's 1991 decision to recommend that all infants receive the Hepatitis B vaccine also had close ties to vaccine manufacturers. Dr. Sam Katz was the advisory committee chairman at the time. A professor at Duke, Katz said 30 percent of children who get the disease get it from unknown causes, possibly in daycare.
He said the CDC tried to give the shots to teens, but it was hard to get them to show up for all three doses.
’So they said, 'Well, we've got a captive audience and we want to give it to the newborns anyways.'"
Katz developed a measles vaccine now manufactured by Merck, which also manufactures a Hepatitis B vaccine. Katz said when he was chairman of the committee in 1991 he also worked as a paid consultant for Merck, Wyeth and most major vaccine manufacturers.”
Please read our Thimerosal and Autism Timeline including the links to source documents here: http://ow.ly/yD5B0